½ÃÀ庸°í¼­
»óǰÄÚµå
1547432

¼¼°èÀÇ °³ÀÎ ½Äº° ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)

Global Human Identification Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 181 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

°³ÀÎ ½Äº° ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 29¾ï 4, 000¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â ¾à 74¾ï 4, 000¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)Àº 10.85%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

°³ÀÎ ½Äº°¿¡´Â ´Ù¾çÇÑ ¹æ¹ý°ú ±â¼úÀ» »ç¿ëÇÏ¿© °³ÀÎÀÇ ½Å¿øÀ» È®ÀÎÇÏ´Â °ÍÀÌ Æ÷ÇԵ˴ϴÙ. Áö¹®, ¾ó±¼ Ư¡, ȫä ÆÐÅÏ, DNA, ¼º¹® µîÀÇ °íÀ¯ÇÑ »ý¹°ÇÐÀû Ư¡(»ýüÀνĽº)À» ¼öÁýÇÏ°í ºÐ¼®ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Æ¯¼ºÀº µðÁöÅÐ ¹æ½ÄÀ¸·Î ĸó, ÀúÀå, ¾Ë·ÁÁø µ¥ÀÌÅͺ£À̽º ¶Ç´Â ÂüÁ¶ »ùÇðú ºñ±³µÇ¾î ID¸¦ È®ÀÎÇϰųª ¼³Á¤ÇÕ´Ï´Ù. º¸¾È, ¹ý ÁýÇà, °úÇÐ ¼ö»ç, ÀÔÅð½Ç °ü¸® ½Ã½ºÅÛ, ÀÇ·á ¿ëµµ¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ

°³ÀÎ ½Äº° ½ÃÀåÀº »ýüÀνĽº ±â¼úÀÇ Áøº¸¿Í ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÃÄ ¾ÈÁ¤ÀûÀÌ°í ¾ÈÀüÇÑ ½Äº° ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó °ßÀεǰí ÀÖ½À´Ï´Ù. ¾ó±¼ ÀνÄ, Áö¹® ÀνÄ, DNA ÇÁ·ÎÆÄÀϸµ, ȫä ½ºÄµ µîÀÇ »ýüÀνĽº ¹æ½ÄÀº °³ÀÎÀÇ ½Å¿øÀ» È®ÀÎÇÒ ¶§ÀÇ Á¤È®¼º°ú È¿À²¼ºÀ¸·Î °¢±¤À» ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº º¸¾È ¹× ÀÎÁõÀÌ Áß¿äÇÑ ¹ý ÁýÇà ±â°ü, ±¹°æ °ü¸®, ÀÇ·á, ÀºÇà, Á¤ºÎ ¼­ºñ½º µî¿¡¼­ ÀÀ¿ëµË´Ï´Ù. ¶ÇÇÑ »çÀ̹ö ¹üÁË¿Í °³ÀÎ Á¤º¸ µµ³­ »ç°ÇÀÌ Áõ°¡ÇÔ¿¡ µû¶ó µ¥ÀÌÅÍ º¸¾ÈÀ» ³ôÀÌ°í ¹«´Ü ¾×¼¼½º¸¦ ¹æÁöÇϱâ À§ÇÑ »ýüÀνĽº ID ½Ã½ºÅÛÀÇ Ã¤¿ëÀÌ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. ½Ã¹Î ¼­ºñ½º ¹× ±¹°¡ ¾Èº¸¸¦ À§ÇØ »ýüÀÎ½Ä ID¸¦ Àǹ«È­ÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í °­È­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ AI ¹× ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀ» Æ÷ÇÔÇÑ ±â¼ú Çõ½ÅÀº »ýü ÀÎ½Ä ½Äº° ÇÁ·Î¼¼½ºÀÇ ¼Óµµ¿Í Á¤È®¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ±â¾÷°ú Á¤ºÎ°¡ µ¥ÀÌÅÍ º¸È£ ¹× ±ÔÁ¦ Áؼö¸¦ ¼±È£ÇÏ´Â µ¿¾È °³ÀÎ ½Äº° ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î È®´ëµÉ °ÍÀÔ´Ï´Ù. »ýüÀνĽº ¼Ö·ç¼ÇÀ» ÁøÈ­½Ã۰í ÁøÈ­ÇÏ´Â º¸¾È °úÁ¦¸¦ È¿°úÀûÀ¸·Î ÇØ°áÇÏ·Á¸é ±â¼ú °³¹ßÀÚ, ½Ã½ºÅÛ ÅëÇÕÀÚ ¹× ÃÖÁ¾ »ç¿ëÀÚ °£ÀÇ Çù·ÂÀÌ ÇʼöÀûÀÔ´Ï´Ù. ±×·¯³ª »ýüÀÎ½Ä µ¥ÀÌÅÍ »ç¿ë¿¡ ´ëÇÑ À±¸®Àû ¿ì·Á¿Í ±ÔÁ¦ Á¦ÇÑÀº ¾ÕÀ¸·Î ¼ö³â°£ °³ÀÎ ½Äº° ½ÃÀåÀÇ ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´ë»óÀ¸·Î ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ µµ±¸´Â °³ÀÎ ½Äº° ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. °³ÀÎ ½Äº° »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ Àü¹ÝÀûÀÎ Á¢±Ù¹ýÀ» ¼³¸íÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

°³ÀÎ ½Äº° ½ÃÀå Á¶»ç º¸°í¼­ÀÇ ÀÌ ¼½¼Ç¿¡¼­´Â ±¹°¡º° ¹× Áö¿ªº° ºÎ¹®¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇϰí Àü·« ´ã´çÀÚ°¡ °¢ Á¦Ç° ¹× ¼­ºñ½ºÀÇ ´ë»ó °èÃþÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ´Â ÇâÈÄ ºñÁî´Ï½º ±âȸ¸¦ Áö¿øÇÕ´Ï´Ù.

Áö¿ª ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­ °³ÀÎ ½Äº° ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ, Àú¸íÇÑ ¸ðµç Áö¿ª¿¡¼­ÀÇ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä, ÃßÁ¤, ¿¹Ãø¿¡µµ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.

¿äûÀÌ ÀÖÀ¸½Ã¸é ÀúÈñ¿¡°Ô ¿¬¶ôÇϽʽÿÀ. ´ç»çÀÇ ¼³¹®Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ½ÃÀå ÇöȲ

Á¦3Àå °³ÀÎ ½Äº° - »ê¾÷ ºÐ¼®

  • ¼Ò°³ : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü À϶÷
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀ̾î À϶÷
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå °³ÀÎ ½Äº° ½ÃÀå ºÐ¼® : Á¦Ç° ¹× ¼­ºñ½ºº°

  • Á¦Ç° ¹× ¼­ºñ½ºº° °³¿ä
  • Á¦Ç° ¹× ¼­ºñ½ºº° °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • ¼Ò¸ðǰ(¾î¼¼ÀÌ Å°Æ® ¹× ½Ã¾à, DNA ÃßÃâ ŰƮ ¹× ½Ã¾à, DNA Á¤·® ŰƮ ¹× ½Ã¾à, DNA ÁõÆø ŰƮ ¹× ½Ã¾à, Àü±â¿µµ¿ ŰƮ ¹× ½Ã¾à, ½Å¼Ó DNA ºÐ¼® ŰƮ ¹× ½Ã¾à)
  • ±âŸ ¼Ò¸ðǰ
  • ¼­ºñ½º(±â±â, ¼ÒÇÁÆ®¿þ¾î)

Á¦6Àå Àΰ£ ½Äº° ½ÃÀå ºÐ¼® : ±â¼úº°

  • ±â¼úº° °³¿ä
  • ±â¼úº° °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(PCR)
  • Â÷¼¼´ë ½ÃÄö¼­(NGS)
  • ¸ð¼¼°ü Àü±â ¿µµ¿
  • ÇÙ»ê ºÐ¸®, Á¤Á¦
  • ÀÚµ¿ ¸®Äûµå Çڵ鸵
  • ¸¶ÀÌÅ©·Î¾î·¹ÀÌ
  • ½Å¼Ó DNA ºÐ¼®

Á¦7Àå Àΰ£ µ¿Á¤ ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ¿ëµµº° °³¿ä
  • ¿ëµµº° °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • ¹ýÀÇÇÐ ¿ëµµ
  • ºÎÀÚ °¨Á¤
  • ±âŸ

Á¦8Àå °³ÀÎ ½Äº° ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°

  • ÃÖÁ¾ »ç¿ëÀÚº° °³¿ä
  • ÃÖÁ¾ »ç¿ëÀÚº° °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • ¹ýÀÇÇÐ ¿¬±¸¼Ò
  • ¿¬±¸¼¾ÅÍ, Çмú, Á¤ºÎ±â°ü

Á¦9Àå °³ÀÎ ½Äº° ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼Ò°³
  • ºÏ¹ÌÀÇ ¸ÅÃ⠺м®
    • °³¿ä : ºÐ¼® ¹× ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ¸ÅÃ⠺м®
    • °³¿ä : ºÐ¼® ¹× ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ¸ÅÃ⠺м®
    • °³¿ä : ºÐ¼® ¹× ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä : ºÐ¼® ¹× ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä : ºÐ¼® ¹× ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º° À϶÷
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå °³ÀÎ ½Äº° ±â¾÷°æÀï ±¸µµ

  • °³ÀÎ ½Äº° ½ÃÀåÀÇ °æÀï
  • Á¦ÈÞ/Çù·Â/ÇÕÀÇ
  • ÇÕº´ ¹× Àμö
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • LGC Limited
  • Qiagen NV
  • Integenx Inc.
  • Thermo Fisher Scientific Inc.
  • Laboratory Corporation Of America Holdings
  • Eurofins Scientific
  • Agilent Technologies Inc.
  • Promega Corporation
  • Illumina Inc.
  • General Electric Company(GE Healthcare)
  • NMS Labs Inc.
  • Hamilton Company
BJH 24.09.24

The global demand for Human Identification Market is presumed to reach the market size of nearly USD 7.44 Billion by 2032 from USD 2.94 Billion in 2023 with a CAGR of 10.85% under the study period 2024-2032.

Human identification involves establishing an individual's identity using various methods and technologies. It collects and analyzes unique biological characteristics (biometrics) such as fingerprints, facial features, iris patterns, DNA, or voiceprints. These characteristics are digitally captured, stored, and compared against known databases or reference samples to verify or establish identity. It is crucial for security, law enforcement, forensic investigations, access control systems, and healthcare applications.

MARKET DYNAMICS

The human identification market is driven by advancements in biometric technologies and the increasing demand for reliable and secure identification solutions across various sectors. Biometric methods such as facial recognition, fingerprint recognition, DNA profiling, and iris scanning are gaining prominence for their accuracy and efficiency in verifying individual identities. These technologies find applications in law enforcement, border control, healthcare, banking, and government services, where security and authentication are critical. Additionally, the rise in cybercrime and identity theft incidents propels the adoption of biometric identification systems to improve data security & prevent unauthorized access. Government initiatives mandating biometric IDs for citizen services and national security further drive market growth. Moreover, technological innovations, including AI and machine learning algorithms, improve the speed and accuracy of biometric identification processes. As businesses and governments prioritize data protection and regulatory compliance, the human identification market is poised for continuous expansion. Collaboration between technology developers, system integrators, and end-users is essential for advancing biometric solutions and addressing evolving security challenges effectively. However, ethical concerns over biometric data usage and regulatory restrictions may hinder the growth of the human identification market in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Human Identification. The growth and trends of Human Identification industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Human Identification market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

  • Consumables (Assay Kits & Reagents, DNA Extraction Kits and Reagents, DNA Quantification Kits and Reagents, DNA Amplification Kits and Reagents, Electrophoresis Kits and Reagents, Rapid DNA Analysis Kits and Reagents)
  • Other Consumables
  • Services (Instruments, Software)

By Technology

  • Polymerase Chain Reaction (PCR)
  • Next-generation Sequencing (NGS)
  • Capillary Electrophoresis
  • Nucleic Acid Isolation and Purification
  • Automated Liquid Handling
  • Microarrays
  • Rapid DNA Analysis

By Application

  • Forensic Application
  • Paternity Testing
  • Other Applications

By End-User

  • Forensic Laboratories
  • Research Center, Academic & Government Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Human Identification market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Human Identification market include LGC Limited, Qiagen N.V., Integenx Inc., Thermo Fisher Scientific Inc., Laboratory Corporation Of America Holdings, Eurofins Scientific, Agilent Technologies Inc., Promega Corporation, Illumina Inc., General Electric Company (GE Healthcare), NMS Labs Inc., Hamilton Company. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. HUMAN IDENTIFICATION - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Service
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HUMAN IDENTIFICATION MARKET ANALYSIS BY PRODUCT & SERVICE

  • 5.1. Overview By Product & Service
  • 5.2. Historical and Forecast Data Analysis By Product & Service
  • 5.3. Consumables (Assay Kits & Reagents, DNA Extraction Kits and Reagents, DNA Quantification Kits and Reagents, DNA Amplification Kits and Reagents, Electrophoresis Kits and Reagents, Rapid DNA Analysis Kits and Reagents) Historic and Forecast Sales By Regions
  • 5.4. Other Consumables Historic and Forecast Sales By Regions
  • 5.5. Services (Instruments, Software) Historic and Forecast Sales By Regions

6. GLOBAL HUMAN IDENTIFICATION MARKET ANALYSIS BY TECHNOLOGY

  • 6.1. Overview By Technology
  • 6.2. Historical and Forecast Data Analysis By Technology
  • 6.3. Polymerase Chain Reaction (PCR) Historic and Forecast Sales By Regions
  • 6.4. Next-generation Sequencing (NGS) Historic and Forecast Sales By Regions
  • 6.5. Capillary Electrophoresis Historic and Forecast Sales By Regions
  • 6.6. Nucleic Acid Isolation and Purification Historic and Forecast Sales By Regions
  • 6.7. Automated Liquid Handling Historic and Forecast Sales By Regions
  • 6.8. Microarrays Historic and Forecast Sales By Regions
  • 6.9. Rapid DNA Analysis Historic and Forecast Sales By Regions

7. GLOBAL HUMAN IDENTIFICATION MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Forensic Application Historic and Forecast Sales By Regions
  • 7.4. Paternity Testing Historic and Forecast Sales By Regions
  • 7.5. Other Applications Historic and Forecast Sales By Regions

8. GLOBAL HUMAN IDENTIFICATION MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-User
  • 8.2. Historical and Forecast Data Analysis By End-User
  • 8.3. Forensic Laboratories Historic and Forecast Sales By Regions
  • 8.4. Research Center, Academic & Government Institutes Historic and Forecast Sales By Regions

9. GLOBAL HUMAN IDENTIFICATION MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE HUMAN IDENTIFICATION COMPANIES

  • 10.1. Human Identification Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF HUMAN IDENTIFICATION INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. LGC Limited
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Qiagen N.V.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Integenx Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Thermo Fisher Scientific Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Laboratory Corporation Of America Holdings
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Eurofins Scientific
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Agilent Technologies Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Promega Corporation
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Illumina Inc.
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. General Electric Company (GE Healthcare)
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. NMS Labs Inc.
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Hamilton Company
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦